Biotech

All Articles

Ideaya bags option on Biocytogen bispecific ADC in $400M offer

.Ideaya Biosciences is betting $400 thousand in biobucks that a bispecific antibody-drug conjugate (...

Takeda takes $140M reduction on neglected epilepsy medication, boasts FDA operate

.Our team already understand that Takeda is wishing to find a road to the FDA for epilepsy medicatio...

VBI Vaccines apply for bankruptcy, looks for resource sale

.Immunology biotech VBI Injections is actually turning alarmingly near to the climax, with strategie...

Celldex anti-cKIT antibody lessen hives in yet another stage 2 study

.It's not easy to muscular tissue in on a space as very competitive as immunology, however Celldex R...

Boehringer offers up to $1.3 B for gate prevention biotech

.Boehringer Ingelheim is actually offering up to $1.3 billion for Nerio Therapies and a preclinical ...

Ventyx's last resort for inflammatory med ends in Crohn's failing

.Ventyx Biosciences' Crohn's disease medication performed not help individuals attain remission in a...

Cognition's stage 2 radiate records tarnish Alzheimer's possibility

.Cognition Therapeutics' phase 2 luster test has taken some of the gloss off the Alzheimer's conditi...

BMS centers bispecific months after filing to operate stage 3 trial

.Bristol Myers Squibb has actually possessed a whiplash change of mind on its BCMA bispecific T-cell...

Charles Baum takes control of Terremoto as chief executive officer

.Charles Baum, M.D., Ph.D., that managed Mirati Therapies' $ 5.8 billion purchase to Bristol Myers S...

Asarina to shut after initiatives to companion Tourette's drug neglect

.After reaching out to much more than 200 business to companion a Tourette syndrome therapy that sho...